The largest database of trusted experimental protocols

Cystamine dihydrochloride

Manufactured by Thermo Fisher Scientific
Sourced in Germany, Belgium

Cystamine dihydrochloride is a chemical compound used in various research and laboratory applications. It serves as a reducing agent and is commonly utilized in biochemical and analytical procedures. The compound's core function is to facilitate redox reactions and provide a source of reactive sulfhydryl groups in experimental setups.

Automatically generated - may contain errors

6 protocols using cystamine dihydrochloride

1

Polymer Synthesis and Transfection Reagents

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lipofectamine 2000 (Invitrogen, Carlsbad, CA), Opti-MEM I (Invitrogen), pEGFP-N1 DNA (Elim Biopharmaceuticals, Hayward, CA), pDsRed-Max-N139 (link) (Addgene DNA plasmid 21718, Cambridge, MA), and cell culture media components were used as received. Monomers used for synthesizing polymers (Scheme 1) were purchased as follows: 1,3-butanediol diacrylate (B3b; Sigma-Aldrich, St. Louis, MO); 1,4-butanediol diacrylate (B4; Alfa Aesar, Ward Hill, MA); 1,5-pentanediol diacrylate (B5; Monomer-Polymer and Dajac Laboratories, Trevose, PA); 3-amino-1-propanol (S3; Alfa Aesar); 4-amino-1-butanol (S4; Alfa Aesar); 5-amino-1-pentanol (S5; Alfa Aesar); 1,3-diaminopropane (E1; Sigma-Aldrich); 1,3-diaminopentane (E3; TCI America, Portland, OR); 2-methyl-1,5-diaminopentane (E4; TCI America); 1,11-diamino-3,6,9-trioxaundecane (E5; TCI America); 2-(3-aminopropylamino)ethanol (E6; Sigma-Aldrich); 1-(3-aminopropyl)-4-methylpiperazine (E7; Alfa Aesar); 1-(3-aminopropyl)pyrrolidine (E8; TCI America); and cystamine dihydrochloride (E10; Alfa Aesar). 4′,6-Diamidino-2-phenylindole dihydrochloride (DAPI) was purchased from Sigma and used as a 750 nM solution in PBS. Other materials were reagent grade.
+ Open protocol
+ Expand
2

Synthesis of Compounds 8 and 10

Check if the same lab product or an alternative is used in the 5 most similar protocols
3,3’-Dichloropivalic acid, triphenylphosphine, ethylamine, 4 M HCl/dioxane and dithiothreitol were purchased from Sigma-Aldrich, Europe (Taufkirchen, Germany). Cystamine dihydrochloride was purchased from Alfa-Aesar (Karlsruhe, Germany), β-Alanine from Fluka (Taufkirchen, Germany) and amoxicillin sodium salt from GlaxoSmithKline (Madrid, Spain). Solvents were obtained from Sigma-Aldrich and Merck (Madrid, Spain), and they were used as received without further purification unless stated. Compounds 8 and 10 were prepared according to a previously published synthetic procedure [20 (link),21 (link)].
+ Open protocol
+ Expand
3

Synthesis of Lysine-Based Biodegradable Polymers

Check if the same lab product or an alternative is used in the 5 most similar protocols
ε-Caprolactone (ε-CL, 99%; Alfa Asear, Thermo Fisher Scientific, USA) and 2,2′-dithiodiethanol (98%; Alfa Aesar) were dried over CaH2 and vacuum distilled before use. L-Lysine diisocyanate (LDI, 99+%; Acros, Acros Organics, Belgium) and stannous octoate (96%; Alfa Aesar) were used as received. Poly(ethylene glycol) (mPEG-OH, 5 ​kDa; Alfa Aesar) was dried by azeotropic distillation from toluene. p-Nitrophenyl chloroformate (p-NPC, 97%; Alfa Aesar) and cystamine dihydrochloride (>98%; Alfa Aesar) were used as received. Toluene and N,N-dimethylformamide (DMF), purchased from Chinasun Specialty Products Co. Ltd, Changshu, China, were dried over CaH2 and vacuum distilled before use.
+ Open protocol
+ Expand
4

Molecular Regulation of Phagocytosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transcriptional activation of RAR‐reporter constructs by tRA was found to be maximal between 0.1 and 10 μM (Allenby et al. 1993), and experiments with glial cultures showed strong effects with 0.01–1 μM (van Neerven, Regen, et al., 2010). To test the molecular regulation of phagocytosis we therefore tested 10 nM, 0.1 μM, and 0.5 μM of the pan‐RAR agonist all‐tRA (R2625; Sigma); 0.1 and 0.5 μM pan‐RXR agonist bexarotene (153559‐49‐0; LC Laboratories); 1 μM pan‐RXR antagonist UVI3003 (3303; Tocris); 1 μM RARβ agonist‐RARα/γ antagonist BMS189453 (SML1149; identical to BMS453; Sigma); 1 and 10 μM pan LXR agonist T0901317 (Cay71810‐10; Cayman); 9 and 18 μM PPARα agonist fenofibrate (Cay10005368‐1; Cayman); 50 nM and 0.1 μM PPARγ antagonist rosiglitazone (LKT‐R5773.100; LKT Laboratories); 0.2 and 0.5 μM PPARβ/δ agonist GW501516 (Cay10004272‐1; Cayman); 1 and 2 μM FXR agonist GW4064 (Cay10006611‐5; Cayman); 0.5 and 1 μM TGM2 inhibitor cystamine dihydrochloride (B22873.14; Alfa Aesar); 15, 25, 50, and 100 μM TGM2 inhibitor ERW1041E (5095220001; Merck); and 1, 5, and 25 μM blocker of scavenger receptor CD36 sulfo‐N‐succinimidyl oleate (SSO; SML2148; Merck).
+ Open protocol
+ Expand
5

Formulation and Characterization of Cysteamine-Based Eye Drops

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cysteamine hydrochloride (cysteamine purity 97%) was obtained from Apollo Scientific (Stockport, UK) and 1-Heptanesulphone acid sodium salt was obtained from Sigma Aldrich (St. Louis, MO, USA). Cystamine dihydrochloride (Cystamine purity 97%) was obtained from Thermo Fisher Scientific (Geel, Belgium). Aquoral® eye drops (0.4% w/v % hyaluronic acid (HA), sodium chloride, sodium citrate, citric acid monohydrate, water for injectable preparations) were purchased from Esteve (Barcelona, Spain). Acetonitrile UHPLC-MS grade and acetic acid were purchased from VWR Chemicals (Radnor, PA, USA). Balanced Salt Solution (BSS®) was purchased from Alcon (Geneva, Switzerland). Ultrapure water from MilliQ, Merck Millipore (Madrid, Spain) was used. As a packaging material, COL Eye Drops System® made with polyvinyl chloride (PVC) and di-n-octyl phthalate/di(2-ethylhexyl) phthalate (DOP/DEHP), free from Biomed Device (Modena, Italy), were used as single-dose containers.
+ Open protocol
+ Expand
6

Synthesis and Characterization of Fluorescent Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cystamine dihydrochloride (97%), N,N-diisopropylethylamine (DIPEA, peptide
synthesis grade), N-carbobenzyloxy-l-valine
(>99%), O-(benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium
tetrafluoroborate (TBTU, 99%), N-carbobenzyloxy-l-tryptophan (98%), hydrogen bromide (pure, 33 wt % solution
in glacial acetic acid), and Nile red (99%) were purchased from Thermo
Fisher Scientific. 1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU, ≥99.0%),
sodium hydroxide pellets (≥98.0%), and pyrene (98%) were ordered
from Sigma-Aldrich. N-Carbobenzyloxy-l-phenylalanine
(99.6%) was ordered from Cymitquimica-Bachem; hydrochloric acid (37%)
from LABBOX-España; magnesium sulfate anhydrous, extrapure,
from Scharlau; uranyl acetate 1% solution (depleted uranium) from
Electron Microscopy Sciences; and tris(2-carboxyethyl)phosphine hydrochloride
(TCEP, >98%) from TCI chemicals. Acetate buffer was prepared by
dissolving
sodium acetate anhydrous (99%) and glacial acetic acid (99%) in water,
both purchased from Thermo Fisher Scientific.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!